1. Impact of brain tumour treatment on quality of life

   • Jan J. Heimans
   • Martin J. B. Taphoorn

   ENS TEACHING REVIEW 15 July 2014 Pages: 955 - 960

2. Excessive action monitoring in Tourette syndrome

   • Sönke Johannes
   • Bernardina M. Wieringa
   • Thomas F. Münte

   ORIGINAL COMMUNICATION 15 July 2014 Pages: 961 - 966

3. Exclusion of linkage of nine neuronal nicotinic acetylcholine receptor subunit genes expressed in brain in autosomal dominant nocturnal frontal lobe epilepsy in four unrelated families

   • Maria Teresa Bonati
   • Romina Combi
   • Maria Luisa Tenchini

   ORIGINAL COMMUNICATION 15 July 2014 Pages: 967 - 974

4. Visual event-related potential changes in two subtypes of multiple system atrophy, MSA-C and MSA-P

   • Toshiaki Kamitani
   • Yoshiyuki Kuroiwa
   • Sho Matsubara

   ORIGINAL COMMUNICATION 15 July 2014 Pages: 975 - 982

5. Modafinil in treatment of fatigue in multiple sclerosis

   • Udo A. Zifko
   • Monika Rupp
   • Eva M. Maida

   ORIGINAL COMMUNICATION 15 July 2014 Pages: 983 - 987

6. Percutaneous arterial interventional treatment of exercise-induced neurogenic intermittent claudication due to ischaemia of the lumbosacral plexus

   • Walter A. Wohlgemuth
   • Manfred Stoehr

   ORIGINAL COMMUNICATION 15 July 2014 Pages: 988 - 992

7. Emotional processing in Parkinson's disease

   • E. Troisi
   • A. Peppe
   • C. Caltagirone

   ORIGINAL COMMUNICATION 15 July 2014 Pages: 993 - 1000

8. sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis - a cross-sectional pilot study

   • Peter Flachenecker
   • Stefan Jung
   • Klaus V. Toyka

   ORIGINAL COMMUNICATION 15 July 2014 Pages: 1001 - 1003

9. Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle

   • Takao Mitsui
   • Hiroyuki Azuma
   • Toshio Matsumoto

   ORIGINAL COMMUNICATION 15 July 2014 Pages: 1004 - 1009

10. Relationship between urinary symptoms and disease-related parameters in multiple sclerosis

    • I. Araki
    • M. Matsui
    • T. Saida

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1010 - 1015

11. Normal dopamine transporter binding in dopa responsive dystonia

    • Chin-Chang Huang
    • Tzu-Chen Yen
    • Chin-Song Lu

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1016 - 1020

12. Determinants of lumbar CSF protein concentration

    • Sepp Seyfert
    • Volker Kunzmann
    • Andreas Faulstich

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1021 - 1026

13. The impact of outpatient rehabilitation on quality of life in multiple sclerosis

    • Francesco Patti
    • Maria Rita Ciancio
    • Arturo Reggio

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1027 - 1033

14. Low prevalence of ataxic polyneuropathy in a community with high exposure to cyanide from cassava foods

    • O. S. A. Oluwole
    • A. O. Onabolu
    • H. Link

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1034 - 1040

15. Electrophysiological brainstem testing in the diagnosis of reversible brainstem ischemia

    • Juergen J. Marx
    • Annette Mika-Gruettner
    • Hanns C. Hopf

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1041 - 1047

16. Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations

    • Lucienir M. Silva
    • Aglair B. Garcia
    • Eduardo A. Donadi

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1048 - 1054

17. Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma

    • Thomas Zander
    • Willy Nettekoven
    • Uwe Schlegel

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1055 - 1057

18. Combination therapy with interferon Beta-1b and azathioprine in secondary progressive multiple sclerosis

    • Oscar Fernández
    • Miguel Guerrero
    • Enrique de Ramón

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1058 - 1062

19. Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease

    • Patricia Pozo-Rosich
    • Pablo Villoslada
    • Xavier Montalban

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1063 - 1065

20. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?

    • T. Schmidt
    • K. Rüther
    • B. Schmitz

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1066 - 1071

21. MR correlates of cerebral atrophy in patients with multiple sclerosis

    • Nicola De Stefano
    • Giuseppe Iannucci
    • Massimo Filippi

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1072 - 1077

22. Idiopathic intracranial hypertension in pregnancy

    • Ruth Huna-Baron
    • Mark J. Kupersmith

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1078 - 1081

23. Correlation between automated writing movements and striatal dopaminergic innervation in patients with Wilson's disease

    • Wieland Hermann
    • Birk Eggers
    • Armin Wagner

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1082 - 1087

24. Hematopoietic stem cell transplantation for multiple sclerosis

    • A.S. Fassas
    • J. R. Passweg
    • for the Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation)

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1088 - 1097

25. Stroke, cerebral artery dissection, and cervical spine manipulation therapy

    • Scott Haldeman
    • Frank J. Kohlbeck
    • Marion McGregor

    ORIGINAL COMMUNICATION 15 July 2014 Pages: 1098 - 1104

26. Cerebrovascular complications of therapeutic neck manipulation

    • P. M. Rothwell
    • J. W. Norris

    SHORT COMMENTARY 15 July 2014 Pages: 1105 - 1106

27. Neurocysticercosis and the global world

    • Hector H. Garcia
    • Javier Pretell
    • for The Cysticercosis Working Group in Peru

    Letter to the Editors 15 July 2014 Pages: 1107 - 1108

28. MR brain changes following terpentine oil ingestion

    • Thomas Seifert
    • Giorgio Giacomini
    • Franz Fazekas

    Letter to the Editors 15 July 2014 Pages: 1109 - 1110

29. Severe acute cerebrovascular disease revealing hepatitis C virus infection: effectiveness of alpha-interferon

    • E. Marchioni
    • M. Ceroni
    • G. Ricevuti

    LETTER TO THE EDITORS 15 July 2014 Pages: 1111 - 1113

30. Quetiapine in Huntington’s disease: a first case report

    • Raphael M. Bonelli
    • Gerald Niederwieser

    Letter to the Editors 15 July 2014 Pages: 1114 - 1115

31. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/hyperactivity disorder: positive effect of methylphenidate

    • Klaus-Henning Krause
    • Stefan Dresel
    • Hanns Lochmüller

    Letter to the Editors 15 July 2014 Pages: 1116 - 1118

32. Internuclear ophthalmoplegia as the first sign of neuroborreliosis

    • Willem J. Hardon
    • Hans J. J. A. Bernsen
    • Bert Mulder

    Letter to the Editors 15 July 2014 Pages: 1119 - 1120

33. Remission of a CNS inflammatory disease accompanied by newly developed ANA and arthropathy during treatment with IFN-β

    • Anne-Christine Karow
    • Jürgen Braun
    • Martin Stangel

    Letter to the Editors 15 July 2014 Pages: 1121 - 1122

34. Cerebral venous thrombosis: Correlation between recanalization and clinical outcome — a long-term follow-up of 40 patients

    • M. Strupp
    • M. Covi
    • T. Brandt

    Letter to the Editors 15 July 2014 Pages: 1123 - 1124

35. Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer’s disease

    • Kazutomi Kanemaru
    • Hiroshi Yamanouchi

    Letter to the Editors 15 July 2014 Pages: 1125 - 1126

36. Exclusion of the Nurr1 gene in autosomal recessive Parkinson’s disease

    • Nina Rawal
    • Magali Periquet
    • Alexis Brice

    Letter to the Editors 15 July 2014 Pages: 1127 - 1129

37. Hans Berger (1873–1941)

    • Kazimierz Karbowski

    Pioneers in Neurology 15 July 2014 Pages: 1130 - 1131

38. HIV-1 associated encephalopathy and myelopathy

    • Ch. Eggers
    • for the German Neuro-AIDS Working Group

    UNREVIEWED CONSENSUS STATEMENT 15 July 2014 Pages: 1132 - 1136

39. Communications

    BriefCommunication 15 July 2014 Pages: 1140 - 1145